Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.ufba.br/handle/ri/7738
metadata.dc.type: | Artigo de Periódico |
Título : | Carbohydrate metabolism in sickle cell patients using a subdermal implant containing nomegestrol acetate (Uniplant) |
Otros títulos : | Contraception |
Autor : | Barbosa, Ione Cristina Ladipo, Oladapo A. Lourdes, Maria de Nascimento, P. Athayde, Célia Maria Soares Hirsch, Cristina Lopes, Renata Matias, Bruno Coutinho, Elsimar Metzker |
metadata.dc.creator: | Barbosa, Ione Cristina Ladipo, Oladapo A. Lourdes, Maria de Nascimento, P. Athayde, Célia Maria Soares Hirsch, Cristina Lopes, Renata Matias, Bruno Coutinho, Elsimar Metzker |
Resumen : | Uniplant, a second-generation contraceptive implant, has been demonstrated to promote a significant improvement in the overall well-being of women with sickle cell anemia. It has been suggested that the discrete increase in blood glucose levels observed in Uniplant users could be a contributory factor for clinical improvement. Ten healthy sickle cell patients were enrolled in the study. An oral glucose tolerance test was performed prior to implant insertion and at 1, 6, and 12 months of therapy. Blood glucose and insulin were measured before and at 30, 60, 120, and 180 min after a 75-g glucose load. The glucose and insulin areas under the curves were calculated. Fasting glycosylated hemoglobin was also measured. No significant changes were observed in glycosylated hemoglobin, glucose or insulin. We conclude that Uniplant is a safe contraceptive for sickle cell patients. |
Palabras clave : | Uniplant Contraceptives Sickle cell Glucose tolerance test |
URI : | http://www.repositorio.ufba.br/ri/handle/ri/7738 |
Fecha de publicación : | 2001 |
Aparece en las colecciones: | Artigo Publicado em Periódico (Faculdade de Medicina) |
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.